The First U.S. Data Show the Monkeypox Vaccine Is Effective
We now have the first real-world data showing how well the monkeypox vaccine is working in the current U.S. outbreak. On Sept. 28, the U.S. Centers for Disease Control and Prevention (CDC) posted preliminary data from 32 jurisdictions in the U.S. that reported monkeypox case rates and rates of vaccination with Jynneos, the vaccine currently being used against monkeypox. By comparing the two, researchers were able to preliminarily quantify how effective the vaccine is, CDC director Dr. Rochelle Walensky said during a briefing. People who had received the first dose of the two-dose Jynneos vaccine were 14 times less likely t...
Source: TIME: Health - September 28, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate monkeypox Source Type: news

Clinic Brings Free Health Care to Homeless Youth -- and Their Beloved Pets
TUESDAY, Sept. 27, 2022 -- Five years back, “Nugget” the Jack-A-Poo was in serious need of some tender loving veterinary care. “He needed vaccinations and a few other things,” Seattle native Grace Stroklund recalled of her sidekick, a Jack... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 27, 2022 Category: General Medicine Source Type: news

Scientists Find a New Coronavirus in Bats That Is Resistant to Current Vaccines
It’s the news that public health experts expect but dread: virus-hunting researchers have discovered a new coronavirus in bats that could spell trouble for the human population. The virus can infect human cells and is already able to skirt the immune protection from COVID-19 vaccines. Reporting in the journal PLoS Pathogens, scientists led by Michael Letko, assistant professor in the Paul Allen School of Public Health at Washington State University, found a group of coronaviruses similar to SARS-CoV-2 that were initially discovered living in bats in Russia in 2020. At the time, scientists did not think the virus, cal...
Source: TIME: Health - September 22, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

Why Infectious Disease Outbreaks Are Becoming So Common
SARS-CoV-2. Monkeypox. Polio. Marburg. These viruses are no longer familiar just to public-health experts, but household names around the world, thanks to their recent incursions into human populations. People have always confronted pathogens of all sorts, but the attacks are becoming more commonplace, and more intense, than they ever have before. “We are going through an era of epidemics and pandemics, and they are going to be more complex and more frequent,” says Jeremy Farrar, director of Wellcome, a global health charitable foundation that addresses health challenges. “We tend to see each [outbreak] i...
Source: TIME: Health - September 15, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Disease feature healthscienceclimate Source Type: news

U.S. Health Agencies Recommend First Omicron Booster Shot
In two votes, each 13-1, the immunization committee of the U.S. Centers for Disease Control and Prevention (CDC) recommended that Americans receive an Omicron-specific booster dose of the COVID-19 vaccine. Following a day-long discussion of the available data on Sept. 1, the panel recommended boosters from two manufacturers—Pfizer-BioNTech and Moderna, both of whom make mRNA-based vaccines; the new booster made by Pfizer-BioNTech is for people 12 years and older, and the Moderna shot is for adults 18 years and older. The group also advised that people wait until at least two months after their previous dose before ge...
Source: TIME: Health - September 2, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

FDA Authorizes Updated Covid Boosters That Target Newest Variants
WASHINGTON — The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common omicron strain. Shots could begin within days. The move by the Food and Drug Administration tweaks the recipe of shots made by Pfizer and rival Moderna that already have saved millions of lives. The hope is that the modified boosters will blunt yet another winter surge. “You’ll see me at the front of the line,” FDA vaccine chief Dr. Peter Marks told The Associated Press shortly before his agency cleared the new doses. Until now, COVID-19 vaccines have targeted the ...
Source: TIME: Health - August 31, 2022 Category: Consumer Health News Authors: Lauran Neergaard/AP Tags: Uncategorized COVID-19 healthscienceclimate wire Source Type: news

Omicron Boosters Are Coming, But They Weren ’t Tested on People. Here’s What You Need to Know
With nearly all the new COVID-19 infections in the U.S. coming from the Omicron BA.4 and BA.5 subvariants, it makes sense that health officials are considering switching to a different vaccine to protect the public. White House COVID-19 response coordinator Dr. Ashish Jha expects the first Omicron-specific booster to be available in mid-September at the earliest, if the U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) authorize and recommend the shot. In late August, both Pfizer-BioNTech and Moderna submitted requests to the FDA for authorization of their Omicron-specific booster...
Source: TIME: Health - August 26, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

U.S. FDA Approves IMBRUVICA ® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
August 24, 2022 (HORSHAM, PA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy. This milestone marks the first pediatric indication for IMBRUVICA® and the introduction of a new oral suspension formulation for patients ages one to less than 12. IMBRUVICA® is now the first FDA-approved therapy for these younger patients who previously had no approv...
Source: Johnson and Johnson - August 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

An Illness Sickening and Killing Dogs in Michigan Is Puzzling Investigators
LANSING, Mich. — State and federal agencies are investigating an unknown illness that’s sickened dogs in northern Michigan and killed at least 30 canines in one county after they exhibited signs of a parvo-like illness. The Michigan Department of Agriculture and Rural Development said it’s working with local animal control shelters, veterinarians, the Michigan State University’s veterinary laboratory, the U.S. Department of Agriculture and other partners on testing to determine the illness’ cause. The state agency said “several dogs” have fallen ill with the same symptoms in the st...
Source: TIME: Health - August 24, 2022 Category: Consumer Health News Authors: Associated Press Tags: Uncategorized healthscienceclimate Public Health wire Source Type: news

Mozambique: Mozambique Purchases Over One Million Vaccines Against Foot and Mouth Disease
[AIM] Maputo -- The Mozambique Veterinary Authority intends to import over a million doses of vaccine against foot-and-mouth disease to respond to the outbreak confirmed in the districts of Chifunde, Mar ávia and Moatize, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 23, 2022 Category: African Health Source Type: news

Mozambique: Mozambique Purchases Foot-and-Mouth Vaccines
[AIM] The Mozambique Veterinary Authority is to import over a million doses of vaccine against foot-and-mouth disease in response to the confirmed outbreak in the districts of Chifunde, Maravia, and Moatize, in the central province of Tete. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 23, 2022 Category: African Health Source Type: news

Pfizer-BioNTech Submits the First Omicron COVID-19 Booster for FDA Authorization
All COVID-19 vaccines that are used in the U.S. target the same original strain of SARS-CoV-2. But boosters designed to protect against the latest Omicron subvariants could be coming soon. On Aug. 22, Pfizer-BioNTech submitted a request to the U.S. Food and Drug Administration (FDA) to authorize its Omicron-specific vaccine. The shot targets BA.4 and BA.5, which now account for nearly all new infections in the U.S. In an announcement, Pfizer-BioNTech requested emergency use authorization for a booster dose of the vaccine, which contains a combination of the genetic material mRNA from the original virus circulating when the...
Source: TIME: Health - August 22, 2022 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

News at a glance: Omicron vaccine, colonial-era exploitation, and mapping health equity
IN FOCUS Scientists rallied outside Canada’s Parliament on 11 August, carrying a 70-meter-long letter with more than 7000 signatures. The letter to lawmakers calls for increases in the stipends paid by graduate student scholarships and postdoctoral fellowships awarded by the Natural Sciences and Engineering Research Council of Canada. “We can’t do science if we can’t pay rent,” one rallygoer’s sign read. COVID-19 U.K. OKs anti-Omicron vaccine The United Kingdom this week became the first country to approve an updated COVID-19 booster directed at two different strains o...
Source: ScienceNOW - August 18, 2022 Category: Science Source Type: news

U.S. Offers Extra Monkeypox Vaccine Doses for Gay Pride Events
NEW YORK — The U.S. is setting aside an extra 50,000 doses of monkeypox vaccine for places with upcoming gay pride events, health officials said Thursday. The number of doses sent to each will be based on factors like the size of the event, how many health workers will be available to give shots, and how many of the attendees are considered at highest risk for catching the virus. “More shots in arms is how we get the outbreak under control,” Bob Fenton, the White House monkeypox response coordinator, told reporters Thursday. He said the effort is an attempt to “meet people where they are.” [ti...
Source: TIME: Health - August 18, 2022 Category: Consumer Health News Authors: Mike Stobbe/AP Tags: Uncategorized healthscienceclimate monkeypox Vaccines wire Source Type: news

Ghana: Ghana Targets 'Zero Human Rabies' By 2030
[Ghanaian Times] Ghana would be able to achieve "Zero human rabies deaths by 2030" through mass dog vaccinations, targeting coverage of 70 per cent and above annually, the Head of Veterinary Epidemiology, Dr Yaw Fenteng Danso, has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - August 16, 2022 Category: African Health Source Type: news